MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.
Zhao L, Liu Y, Tong D, Qin Y, Yang J, Xue M, Du N, Liu L, Guo B, Hou N, Han J, Liu S, Liu N, Zhao X, Wang L, Chen Y, Huang C.
Zhao L, et al. Among authors: liu y, liu n, liu l, liu s.
EBioMedicine. 2017 Feb;16:87-100. doi: 10.1016/j.ebiom.2017.01.021. Epub 2017 Jan 17.
EBioMedicine. 2017.
PMID: 28131747
Free PMC article.